BIOINFORMATICS ARTICLES
-
![GettyImages-2246207235]( "Annual Reflections And Predictions From The Editors' Roundtable")
Annual Reflections And Predictions From The Editors' RoundtableUnderstanding the full scope of the life science industry has never been more critical. Ray Dogum, Chief Editor of Drug Discovery Online, joins the Life Science Connect Editors’ Roundtable on a special episode of Better Biopharma podcast.
-
![advancement innovation-GettyImages-2218939025]( "2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026")
2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026Drug Discovery Online's 2025 Top 5 most consequential shifts affecting this rapidly evolving field, including NAMs, AI, Individualized Therapies, Innovating China, and Early-stage Funding Volatility.
-
![20251118_100400]( "From Funding Gaps to AI Frontiers: Insights from the Boston Globe Summit 2025")
From Funding Gaps to AI Frontiers: Insights from the Boston Globe Summit 2025Insights from the Boston Globe Summit 2025 exploring biotech funding challenges, AI-driven drug discovery, and genome editing breakthroughs shaping the future of research and care.
-
![Science and lab equipment-GettyImages-2168387231]( "Live Insights: 45% Believe The NAMs Industry Should Expand Pre-Competitive Data Sharing Programs")
Live Insights: 45% Believe The NAMs Industry Should Expand Pre-Competitive Data Sharing ProgramsAccording to a recent poll, 45% of participants believe the NAMs industry should expand pre-competitive consortia by sharing validation data and best practices to reduce duplication and accelerate acceptance. Experts Zahar Nahle, Ph.D. and Samantha Atkins, Ph.D. share their insights.
-
![Machine Learning-AI-GettyImages-2236865789]( "Progressing Precision Medicine Discovery With AI")
Progressing Precision Medicine Discovery With AIWe caught up with Iya Khalil, Ph.D., vice president and head of data, AI, and genome sciences at Merck & Co. to discuss Merck's creation of a foundation model that will help progress precision medicine.
-
![GettyImages-2207965610]( "OpenFold3 Released: Redefining The Limits Of Protein Prediction Models")
OpenFold3 Released: Redefining The Limits Of Protein Prediction ModelsOpenFold3, a biomolecular structure prediction model based on AlphaFold3 was recently released by the OpenFold Consortium, a non-profit AI R&D organization.
BIOINFORMATICS VIDEOS
DEL technology is evolving from a screening tool into a rich data engine for AI. Learn how expanding datasets and computational methods are reshaping what researchers can uncover.
Discover how AI-powered modeling uncovers hidden patterns in DEL data, broadens chemical diversity, and accelerates decision-making to help teams prioritize compounds and move more efficiently.
Zaher compares EU and U.S. progress, noting legislative and policy shifts driving NAMS integration. Samantha calls for open data platforms and consortiums to build confidence, while Zaher stresses benchmarking against human clinical data and government-led initiatives akin to the Human Genome Project.
Zaher frames the urgency of NAMS adoption by highlighting the staggering 92% drug failure rate in clinical trials despite animal testing. He explains how interdisciplinary convergence and AI are accelerating the shift toward human-relevant models, positioning NAMS as a solution to systemic inefficiencies in drug development.
BIOINFORMATICS APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2213157127-drug-formulation-discovery-pipette-liquid-vial]( "How One Biotech Company Is Accelerating The Drug Discovery Workflow")
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
![GettyImages-1180547358-computer-research]( "Powering Drug Development With Advanced AI Retrosynthetic Analysis Tools")
Review advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.
-
![AI-artificial intelligence-GettyImages-1464561797]( "Leveraging AI And ML For Better Biologics")
For many bioprocessing applications, both artificial intelligence (AI) and machine learning (ML) can be used in every phase of development to support optimization and streamline repetitive, effort-intensive processes.
-
![Science techonlogy-research-development-discovery-GettyImages-1209662272]( "Revolutionizing Drug Discovery From \"Undruggables\" To AI")
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.
BIOINFORMATICS SOLUTIONS
-
![QIAcuity® Family]( "Digital PCR Analytics For Cell And Gene Therapy Workflows")
Gain precise quantification for CGT workflows with a simple, automated digital PCR approach that improves sensitivity, minimizes hands‑on time, and supports evolving demands from discovery through QC.
-
![Artificial Intelligence (AI) Digital Concept GettyImages-1160995648]( "AI-Enabled Route Scouting Service")
Lonza's Route Scouting Service empowers biotech partners to overcome the complexities of API development and bring life-changing medicines to market faster.
